FDA fast-tracks cellular eye implant
This article was originally published in Clinica
Executive Summary
NT-501, an intraocular, cell-containing polymer implant developed by biotech firm Neurotech USA, has been granted fast-track designation by the US FDA, allowing it to reach the market earlier than would otherwise have been possible.